Search for: "PFIZER" Results 1461 - 1480 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jan 2016, 12:47 pm by Daniel Shaviro
., involving companies in the same industry - such as Burger King and Tim Horton's, or Pfizer and Allergan. [read post]
20 Jan 2016, 8:00 am by Robert Kreisman
Another very expensive drug is Ibrance, a breast cancer drug developed by the pharmaceutical company, Pfizer. [read post]
18 Jan 2016, 6:34 am by Patrick A. Malone
It was unclear whether Soon-Shiong’s project really had the scope he announced, and whether other Big Pharma firms, including Pfizer, Merck, and GlaxoSmithKline, has signed on. [read post]
17 Jan 2016, 8:00 am by Paul Caron
There is a bit of movement in this week's list of the Top 5 Recent Tax Paper Downloads, with a new paper debuting on the list at #5: [319 Downloads] The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79, by Reuven Avi-Yonah (Michigan) [266 Downloads] Conservation Easements and... [read post]
10 Jan 2016, 8:00 am by Paul Caron
There is a bit of movement in this week's list of the Top 5 Recent Tax Paper Downloads, with a new paper debuting on the list at #3: [293 Downloads] The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79, by Reuven Avi-Yonah (Michigan) [173 Downloads] The Effect of... [read post]
8 Jan 2016, 1:30 am by Paul Caron
It’s a “tax inversion”—Pfizer will in effect be reconstituting itself as an Irish company, in order to lower its... [read post]
7 Jan 2016, 1:37 pm by Tom Lamb
From the this December 23, 2015 Reuters news report, "New blood thinner 'antidote' to help doctors move past warfarin", we get some insight about this current "no antidote" situation: Xarelto, from Bayer AG and Johnson & Johnson, and Eliquis, sold by Bristol-Myers Squibb and Pfizer, were approved as safer and more convenient alternatives for preventing blood clots and strokes than warfarin. [read post]
3 Jan 2016, 1:00 am by Paul Caron
There is a bit of movement in this week's list of the Top 5 Recent Tax Paper Downloads, with a new paper debuting on the list at #5: [278 Downloads] The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79, by Reuven Avi-Yonah (Michigan) [204 Downloads] The State Administration... [read post]
27 Dec 2015, 3:17 am by Paul Caron
This week's list of the Top 5 Recent Tax Paper Downloads is the same as last week's list: [254 Downloads] The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79, by Reuven Avi-Yonah (Michigan) [192 Downloads] The State Administration Of International Tax Avoidance, by Omri Y. [read post]
21 Dec 2015, 3:00 am by Paul Caron
Marian (UC-Irvine), Inversions and Competitiveness: Reflections in the Wake of Pfizer/Allergan: The recent announcement that Pfizer Inc. has reached a merger agreement with Allergan PLC , with the combined entity being tax-resident in Ireland, is a good occasion to reconsider U.S. policy options... [read post]
20 Dec 2015, 8:09 am by Paul Caron
There is quite a bit of movement in this week's list of the Top 5 Recent Tax Paper Downloads, with a new #1 paper and new papers debuting on the list at #4 and #5: [230 Downloads] The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79, by Reuven... [read post]
16 Dec 2015, 12:05 pm by Paul Caron
To many students of corporate social responsibility, or CSR, Pfizer’s recent decision to move its headquarters to Ireland may have been perplexing. [read post]
15 Dec 2015, 9:26 am by Daniel Shaviro
Pfizer's operational headquarters will remain in Manhattan - just as the operational headquarters of Allergan, legally resident in Ireland, has remained in Parsippany, New Jersey. [read post]
15 Dec 2015, 3:05 am by Paul Caron
Icahn (Chair, Icahn Enterprises): The Pfizer-Allergan deal is a travesty. [read post]
13 Dec 2015, 4:01 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 75 [week ending on Sunday 6 December] –  BHG on blocking injunctions | IP in Universities | Sweden on blocking injunctions | Canadian musings on patents | US Senate and trade secret reform | Chinese IP Courts | G1/14 referral and Article 108 EPC | PACE procedure (Procedure for Accelerated Conduct of Examination) ant the EPO | Greekat and trade mark partenalism | EPO Boards of Appeal tell AC: we were… [read post]